An interventional study of Hospital-like treatment in patients' home and standard inpatient treatment in Substance Use Disorders, sponsored by Louise Penzenstadler. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-28.
Sponsored by Louise Penzenstadler · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Substance-Related Disorders with a site in Switzerland — 6 open to participants now, 7 under way, none of them phase 3. Substance-Related Disorders · Switzerland.
Among the 27 studies in Substance-Related Disorders with a site in Switzerland, this one is the 10th largest by planned enrollment of the 23 interventional ones that give a count, is the only one that started in 2022, is one of 14 with no phase, and was the 22nd registered.
2,242 studies on the registry are indexed under Substance-Related Disorders; 408 are open to participants now.
Browse Substance-Related Disorders studies →6 of the 27 studies in Substance-Related Disorders with a site in Switzerland are open now. Recruiting first, the newest first:
Psychiatric Services Aargau AG · Sites in Switzerland
Ages 18–64
NORCE Norwegian Research Centre AS · Sites in Switzerland, Austria, Israel and 5 more countries
Ages 18+
Susanne Walitza · Sites in Switzerland
Ages 8–18 · Healthy volunteers
Louise Penzenstadler · Sites in Switzerland
Ages 18+
Prof. Dagmar M. Haller · Sites in Switzerland
Ages 14–24 · Healthy volunteers
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 266 Substance-Related Disorders studies recruiting now, 130 (49%) set no upper age limit and 117 (44%) stop at 75 or younger; 55 take children under 18; 90 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 1 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 108 across 1,844 interventional studies indexed under Substance-Related Disorders.
Median enrollment 28 across the 23 interventional studies, 45 across the 4 observational. Of the 18 that completed or were terminated, 1 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 27 have an industry lead sponsor. The 10 most frequent:
Louise Penzenstadler is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Louise Penzenstadler has 2 studies filed under Substance-Related Disorders — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 27 studies in Substance-Related Disorders with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted.
The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Home visits by care staff at the same frequency as in hospital
Other: Hospital-like treatment in patients' home
Inpatient treatment on hospital ward
Other: standard inpatient treatment
Hospital-like treatment in patients' home. Caregivers, medical doctors and social workers will make several visits per day to the patients' home. 24/7 contact is available.
Inpatient treatment on addiction ward
readmission rates
Number of readmissions to hospital during the 6 months following discharge
Time frame: 6 month post-discharge
time to readmission
Number of days between discharge and readmission during the 6 months following discharge
Time frame: 6 months
length of hospitalization
total number of days spent in hospital during the 6 months following discharge
Time frame: 6 months
number of emergency room visits
number of emergency room visits during the 6 months following discharge
Time frame: 6 months
clinical outcome
clinical outcomes measured with Health of the Nation Outcome scale (HoNOS) scoring 0 (no symptoms) to 48 (high symptom level) and the Brief Symptom Check-List (short form of the Brief Symptom Inventory), scoring 0-53 items (higher score = more symptoms). Measured at the start and end of intervention/hospital treatment.
Time frame: 6 months
patient satisfaction
Patient satisfaction measured with the S-ANQ (https://www.anq.ch/en/), a questionnaire used by all Swiss hospitals to measure patient satisfaction with treatment. The questionnaire includes 6 questions which are marked from 0 not at all satisfied to 5 = very satisfied. Scoring 0 (not at all satisfied) to 30 (very satisfied)
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2022 (actual). Primary completion is estimated for Dec 2025, 36 months after the start.
Of 819 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 53. This study's planned 36 months is close to that.
Counting every sponsor, half of 859 studies reached it within 34 months; a quarter within 17 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Louise Penzenstadler